CIK 0000021665 · Large accelerated filer
COLGATE PALMOLIVE CO
Sign in to watch- Ticker
- CL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131815595
- Phone
- 2123102000
- Business address
- 300 PARK AVE, NEW YORK, NY, 10022
- Former names
- COLGATE PALMOLIVE CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,027,828
- in 6 filings
Net −$8,027,828. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Tsourapas Panagiotis −$2.9M COO, CD, EMEA, APac, Skin sold 77% of stake
- Hazlin John −$2.3M Chief Growth Officer sold 46% of stake
- Wallace Noel R. −$2.0M Chairman, President & CEO sold 5% of stake
- NORRINGTON LORRIE M −$414K Director sold 9% of stake
- Malcolm Gregory −$402K EVP and Controller sold 29% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | SUTULA STANLEY J III Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −97,843 | 0 | ||
| 2026-02-04 | Daniels Jennifer CLO and Secretary | Option exercise | +22,000 | $72.29 | $1.6M | 98,406 |
| 2026-02-04 | Daniels Jennifer CLO and Secretary | Sale | −22,000 | $94.34 | $2.1M | 76,406 |
| 2026-02-04 | Daniels Jennifer CLO and Secretary | Option exercise · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2026-02-04 | Wallace Noel R. Chairman, President & CEO | Sale | −45,568 | $93.91 | $4.3M | 293,188 |
| 2026-01-02 | Newman Brian Director | Grant or award | +238 | $78.66 | $19K | 5,313 |
| 2026-01-02 | NORRINGTON LORRIE M Director | Grant or award | +333 | $78.66 | $26K | 39,648 |
| 2026-01-02 | BILBREY JOHN P Director | Grant or award | +301 | $78.66 | $24K | 37,195 |
| 2025-12-03 | Wallace Noel R. Chairman, President & CEO | Shares withheld for taxes | −1,307 | $78.20 | $102K | 338,756 |
| 2025-12-03 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Shares withheld for taxes | −221 | $78.20 | $17K | 10,415 |
| 2025-12-03 | SUTULA STANLEY J III Chief Financial Officer | Shares withheld for taxes | −385 | $78.20 | $30K | 55,310 |
| 2025-12-03 | Malcolm Gregory EVP and Controller | Shares withheld for taxes | −41 | $78.20 | $3K | 11,879 |
| 2025-12-03 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −156 | $78.20 | $12K | 17,645 |
| 2025-12-03 | Daniels Jennifer CLO and Secretary | Shares withheld for taxes | −213 | $78.20 | $17K | 76,406 |
| 2025-11-21 | Massey Sally Chief Human Resources Officer | Sale | −1,237 | $80.89 | $100K | 13,751 |
| 2025-10-01 | Newman Brian Director | Grant or award | +228 | $82.13 | $19K | 5,065 |
| 2025-10-01 | NORRINGTON LORRIE M Director | Grant or award | +319 | $82.13 | $26K | 39,061 |
| 2025-10-01 | BILBREY JOHN P Director | Grant or award | +289 | $82.13 | $24K | 36,658 |
| 2025-09-13 | Daniels Jennifer CLO and Secretary | Shares withheld for taxes | −900 | $83.28 | $75K | 76,559 |
| 2025-09-13 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −449 | $83.28 | $37K | 17,629 |
Page 7 of 10 · 193 trades